Drug Chatter -- Tracking biopharma stock chatter

Profile for Epizyme, Inc. (EPZM)

« Back to company index

EPZM Chatter Timeline

Stock Ticker for EPZM

Most Active Tweeters for EPZM

UserTweets
@stocknewstimes 12
@SleekMoneycom 11
@dispatchtribune 8
@AmericanBanking 7
@ledgerzette 6

Recent Tweets for EPZM

ledgerzette @ledgerzette
Reviewing Epizyme $EPZM and Its Rivals https://t.co/txQXlJgROO
November 19th 2017, 10:11pm
AmericanBanking @AmericanBanking
Brokerage Give Consensus Buy Rating to Epizyme $EPZM https://t.co/o7pcNBCZjK
November 19th 2017, 9:11am
AmericanBanking @AmericanBanking
Epizyme Receives Consensus Buy Rating from Analysts $EPZM https://t.co/o7pcNBCZjK
November 19th 2017, 9:11am
dispatchtribune @dispatchtribune
Zacks: Analysts Expect Epizyme, Inc. $EPZM Will Post Quarterly Sales of $500,000.00 https://t.co/CCWRpRBo2P
November 19th 2017, 4:11am
MarginHunt @MarginHunt
Steven Cohen owns shares of Universal Health Services, $EPZM and expects a 50% jump https://t.co/TIzoAVPbpC https://t.co/KEz3NeRZO9
November 18th 2017, 9:11pm
SleekMoneycom @SleekMoneycom
Epizyme $EPZM Given News Sentiment Score of 0.20 https://t.co/0wFyzP9kyB
November 18th 2017, 2:11pm
TickerReport @TickerReport
Epizyme $EPZM Given News Sentiment Score of 0.20 https://t.co/Jx7ARoGMs9
November 18th 2017, 2:11pm
emq_news @emq_news
Epizyme $EPZM Given News Sentiment Score of 0.20 https://t.co/7SnKgB4UAX
November 18th 2017, 2:11pm
stocknewstimes @stocknewstimes
Epizyme $EPZM Given News Sentiment Score of 0.20 https://t.co/fyYotrnECS
November 18th 2017, 2:11pm
TickerReport @TickerReport
Epizyme $EPZM Given News Sentiment Score of 0.20 https://t.co/luGtdo09jf
November 18th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Epizyme, Inc. $EPZM Stake Boosted by NEA Management Company LLC https://t.co/TnWcHpOCz4
November 18th 2017, 1:11pm
noritsunagirota @noritsunagirota
Oracle Investment Management Position in Epizyme $EPZM Has Lowered as Share Value Rose https://t.co/tFyX6D28FR
November 18th 2017, 10:11am
SleekMoneycom @SleekMoneycom
Epizyme, Inc. $EPZM Issues Earnings Results, Beats Estimates By $0.02 EPS https://t.co/mg6b6fgFG6
November 18th 2017, 2:11am
stocknewstimes @stocknewstimes
Epizyme, Inc. $EPZM Issues Earnings Results, Beats Estimates By $0.02 EPS https://t.co/FO0WpNIAl1
November 18th 2017, 2:11am
dispatchtribune @dispatchtribune
Leerink Swann Reaffirms “Outperform” Rating for Epizyme, Inc. $EPZM https://t.co/aOr5uLzNWM
November 17th 2017, 10:11pm
ledgerzette @ledgerzette
Epizyme, Inc. $EPZM Rating Reiterated by Cann https://t.co/LtOo6YNBck
November 17th 2017, 7:11pm
dispatchtribune @dispatchtribune
Epizyme, Inc. $EPZM Lowered to “Sell” at ValuEngine https://t.co/mGuJMzXYTB
November 17th 2017, 8:11am
wosaikeneriki @wosaikeneriki
Epizyme $EPZM Shareholder Oracle Investment Management Cut Its Holding by $3.37 Million ...
November 17th 2017, 8:11am
stocknewstimes @stocknewstimes
Epizyme, Inc. Forecasted to Earn FY2017 Earnings of -$2.25 Per Share $EPZM https://t.co/20A9czbNZS
November 17th 2017, 7:11am
SleekMoneycom @SleekMoneycom
Epizyme, Inc. Forecasted to Earn FY2017 Earnings of -$2.25 Per Share $EPZM https://t.co/d5b1MTUIEm
November 17th 2017, 7:11am
ledgerzette @ledgerzette
Epizyme, Inc. $EPZM Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS https://t.co/pa9TanCJAS
November 17th 2017, 5:11am
srqstockpicker @srqstockpicker
RT @odibro: $EPZM tazemetostat granted FDA ODD for the Treatment of follicular lymphoma
November 16th 2017, 7:11am
stocknewsdotcom @stocknewsdotcom
$EPZM Granted orphan drug designation by the FDA for tazemetostat for the treatment of follicular lymphoma https://t.co/dmTv2STJ9P
November 16th 2017, 6:11am
odibro @odibro
$EPZM tazemetostat granted FDA ODD for the Treatment of follicular lymphoma
November 16th 2017, 5:11am
stocknewstimes @stocknewstimes
TIAA CREF Investment Management LLC Grows Stake in Epizyme, Inc. $EPZM https://t.co/xJTcyvxsoY
November 15th 2017, 8:11pm
stocknewstimes @stocknewstimes
Epizyme $EPZM versus The Competition Critical Analysis https://t.co/V76Ry2etgr
November 15th 2017, 12:11pm
dispatchtribune @dispatchtribune
Jennison Associates LLC Sells 9,474 Shares of Epizyme, Inc. $EPZM https://t.co/y5Zw9QY1PP
November 15th 2017, 10:11am
stocknewstimes @stocknewstimes
Oppenheimer Holdings Analysts Lift Earnings Estimates for Epizyme, Inc. $EPZM https://t.co/rmpbqg8rWs
November 15th 2017, 8:11am
SleekMoneycom @SleekMoneycom
Epizyme $EPZM Getting Somewhat Positive Media Coverage, Study Finds https://t.co/ugbSZxs5UH
November 14th 2017, 10:11pm
SleekMoneycom @SleekMoneycom
Cann Reiterates “Buy” Rating for Epizyme, Inc. $EPZM https://t.co/c4E9FyHIWq
November 14th 2017, 3:11pm
stocknewstimes @stocknewstimes
Cann Reiterates “Buy” Rating for Epizyme, Inc. $EPZM https://t.co/RJ5QpMxfzI
November 14th 2017, 3:11pm
ledgerzette @ledgerzette
Leerink Swann Reiterates “Outperform” Rating for Epizyme, Inc. $EPZM https://t.co/3X0ns61o4I
November 14th 2017, 2:11pm
dispatchtribune @dispatchtribune
HC Wainwright Reiterates “Buy” Rating for Epizyme, Inc. $EPZM https://t.co/SjzX8CzUwT
November 14th 2017, 2:11pm
chaffeybreeze @chaffeybreeze
Epizyme, Inc. $EPZM Shares Bought by Alps Advisors Inc. https://t.co/slVY9oGYzW
November 14th 2017, 11:11am
IRAMarketReport @IRAMarketReport
Epizyme, Inc. $EPZM Shares Bought by Alps Advisors Inc. https://t.co/3GP2qJV2co
November 14th 2017, 11:11am
ZolmaxNews @ZolmaxNews
State Street Corp Has $26.64 Million Stake in Epizyme, Inc. $EPZM https://t.co/SPEFb8n83j
November 14th 2017, 6:11am
emq_news @emq_news
Wells Fargo & Company MN Has $470,000 Stake in Epizyme, Inc. $EPZM https://t.co/FDM4EAGIzZ
November 14th 2017, 4:11am
TickerReport @TickerReport
Wells Fargo & Company MN Has $470,000 Stake in Epizyme, Inc. $EPZM https://t.co/nGqAa6RrOH
November 14th 2017, 4:11am
TickerReport @TickerReport
Wells Fargo & Company MN Has $470,000 Stake in Epizyme, Inc. $EPZM https://t.co/S8Qi6DkrjN
November 14th 2017, 4:11am
WeekHerald @WeekHerald
Cann Reaffirms “Buy” Rating for Epizyme, Inc. $EPZM https://t.co/EDZvwoeefn
November 13th 2017, 11:11pm
WeekHerald @WeekHerald
Epizyme, Inc. $EPZM Receives Buy Rating from HC Wainwright https://t.co/mukQkq2NnU
November 13th 2017, 6:11pm
ledgerzette @ledgerzette
Epizyme, Inc. $EPZM Rating Reiterated by HC Wainwright https://t.co/X13NJgoG7f
November 13th 2017, 5:11pm
ledgerzette @ledgerzette
Royal Bank Of Canada Lowers Epizyme, Inc. $EPZM to Sector Perform https://t.co/2ZErSSqZpw
November 13th 2017, 3:11pm
doublehooligan @doublehooligan
$EPZM eyeballing this 13.65 level
November 13th 2017, 1:11pm
noritsunagirota @noritsunagirota
Rock Springs Capital Management LP Upped Its Position in Epizyme $EPZM by $9.08 Million ...
November 13th 2017, 5:11am
stocknewstimes @stocknewstimes
644,081 Shares in Epizyme, Inc. $EPZM Purchased by Lord Abbett & CO. LLC https://t.co/WmMEd6BT06
November 12th 2017, 11:11pm
WatchlistN @WatchlistN
Epizyme $EPZM Receives Daily Coverage Optimism Rating of 0.18 https://t.co/Ary6XHGpsw
November 11th 2017, 2:11pm
stocknewstimes @stocknewstimes
Epizyme, Inc. $EPZM Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS https://t.co/FO0WpNIAl1
November 11th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Epizyme, Inc. $EPZM Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS https://t.co/mg6b6fgFG6
November 11th 2017, 2:11pm
TranscriptDaily @TranscriptDaily
Northern Trust Corp Boosts Holdings in Epizyme, Inc. $EPZM https://t.co/TTt6RMTHxS
November 11th 2017, 6:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.